| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/15/2022 | 364.68% | HC Wainwright & Co. | → $25 | Initiates Coverage On | → Buy |
| 05/17/2022 | 178.81% | Morgan Stanley | $19 → $15 | Maintains | Overweight |
| 08/24/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 08/24/2021 | 476.21% | Morgan Stanley | → $31 | Initiates Coverage On | → Overweight |
| 08/24/2021 | 587.73% | Chardan Capital | → $37 | Initiates Coverage On | → Buy |
| 08/24/2021 | 643.49% | Piper Sandler | → $40 | Initiates Coverage On | → Overweight |
Tenaya Therapeutics Questions & Answers
The latest price target for Tenaya Therapeutics (NASDAQ: TNYA) was reported by HC Wainwright & Co. on June 15, 2022. The analyst firm set a price target for $25.00 expecting TNYA to rise to within 12 months (a possible 364.68% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Tenaya Therapeutics (NASDAQ: TNYA) was provided by HC Wainwright & Co., and Tenaya Therapeutics initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenaya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenaya Therapeutics was filed on June 15, 2022 so you should expect the next rating to be made available sometime around June 15, 2023.
While ratings are subjective and will change, the latest Tenaya Therapeutics (TNYA) rating was a initiated with a price target of $0.00 to $25.00. The current price Tenaya Therapeutics (TNYA) is trading at is $5.38, which is within the analyst's predicted range.